Commenting on the acquisition, Sachidanand Upadhyay, Managing Director, Lord’s Mark Industries Ltd., said: “Our investment in Renalyx is a forward-looking bet on the future of Indian healthcare, one where cutting-edge med-tech is designed, engineered, and manufactured in India for India and the world. Dialysis must move from being a high-cost, infrastructure-heavy service to a smart, connected, and patient-centric experience. By bringing Renalyx into our fold, we are accelerating that shift. We see this as a transformative opportunity to democratise advanced renal care, strengthen Make in India innovation, and build medical technologies that redefine accessibility and clinical excellence at scale.”